“Prevalence of JAK2 V617F mutation in BCR::ABL negative classical myeloproliferative neoplasm along with a comparison of two mutant allele burden detection techniques”, Int. Arch. Biomed. Clin. Res., vol. 10, no. 1, pp. PA5-PA9, Mar. 2024, doi: 10.21276/bb6g4y37.